Informação sobre produto
- 1-(4-(4-Imino-6,7-dimethoxy-3,4-dihydroquinazolin-2-yl)-1,4-diazepan-1-yl)butan-1-one hydrochloride
- 1-Butanone, 1-[4-(4-amino-6,7-dimethoxy-2-quinazolinyl)hexahydro-1H-1,4-diazepin-1-yl]-, hydrochloride (1:1)
- 1-[4-(4-Amino-6,7-Dimethoxyquinazolin-2-Yl)-1,4-Diazepan-1-Yl]Butan-1-One
- 1-[4-(4-Amino-6,7-Dimethoxyquinazolin-2-Yl)-1,4-Diazepan-1-Yl]Butan-1-One Hydrochloride (1:1)
- 1-[4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)-1,4-diazepan-1-yl]butan-1-one hydrochloride
- 1H-1,4-Diazepine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)hexahydro-4-(1-oxobutyl)-, monohydrochloride
- DDQ (pharmaceutical)
- Detantol
- E 643
Bunazosin hydrochloride is a drug used for the treatment of overactive bladder, benign prostatic hypertrophy, and primary pulmonary hypertension. It is a selective antagonist of the α1A-adrenoceptor, which inhibits the release of norepinephrine from nerve endings. The action of this drug is due to its ability to block the binding of norepinephrine to adrenergic receptors in smooth muscle cells. This leads to relaxation of smooth muscle cells in blood vessels, urinary bladder, and bowel. Bunazosin hydrochloride has been shown to reduce edema by inhibiting the accumulation of fluid in tissues. It also reduces congestion by lowering blood pressure and relieving symptoms associated with congestive heart failure. This drug has been shown to be beneficial in treating bowel diseases such as constipation and ulcerative colitis by increasing water permeability in the intestines.
Propriedades químicas
Consulta técnica sobre: 3D-CCA71276 Bunazosin hydrochloride
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.